Drug Name | Pathway ID | Pathway name | P-value | No. of gene members | UniProt AC | Gene name | Detail of Coexpression | |
---|
Caffeine | hsa00030 | Pentose phosphate pathway | 3.06E-04 | 3 | P60891, P51854, P37837 | PRPS1, TKTL1, TALDO1 | More | | Caffeine | hsa00052 | Galactose metabolism | 4.27E-02 | 2 | P06280, O43451 | GLA, MGAM | More | | Caffeine | hsa00053 | Ascorbate and aldarate metabolism | 4.93E-02 | 1 | P14550 | AKR1A1 | More | | Caffeine | hsa00190 | Oxidative phosphorylation | 4.21E-04 | 4 | Q16718, Q13488, P36542, O14521 | NDUFA5, TCIRG1, ATP5C1, SDHD | More | | Caffeine | hsa00220 | Arginine biosynthesis | 1.21E-02 | 1 | P15104 | GLUL | More | | Caffeine | hsa00250 | Alanine, aspartate and glutamate metabolism | 2.42E-02 | 1 | P15104 | GLUL | More | | Caffeine | hsa00340 | Histidine metabolism | 3.28E-02 | 1 | O95954 | FTCD | More | | Caffeine | hsa00500 | Starch and sucrose metabolism | 6.17E-03 | 3 | O43451, P46976, P06737 | MGAM, GYG1, PYGL | More | | Caffeine | hsa00565 | Ether lipid metabolism | 4.93E-02 | 1 | Q8N661 | TMEM86B | More | | Caffeine | hsa00600 | Sphingolipid metabolism | 2.77E-02 | 3 | Q9BX95, Q8TCT0, P15289 | SGPP1, CERK, ARSA | More | | Caffeine | hsa00630 | Glyoxylate and dicarboxylate metabolism | 4.84E-04 | 3 | P40925, P40926, P15104 | MDH1, MDH2, GLUL | More | | Caffeine | hsa00670 | One carbon pool by folate | 4.88E-02 | 1 | O95954 | FTCD | More | | Caffeine | hsa00730 | Thiamine metabolism | 2.27E-02 | 2 | P05186, P24666 | ALPL, ACP1 | More | | Caffeine | hsa00910 | Nitrogen metabolism | 2.42E-02 | 1 | P15104 | GLUL | More | | Caffeine | hsa00983 | Drug metabolism - other enzymes | 5.93E-05 | 3 | P04183, P32320, P05164 | TK1, CDA, MPO | More | | Caffeine | hsa01040 | Biosynthesis of unsaturated fatty acids | 2.92E-02 | 2 | P22307, Q9H5J4 | SCP2, ELOVL6 | More | | Caffeine | hsa01200 | Carbon metabolism | 4.32E-02 | 3 | P51854, P37837, P60891 | TKTL1, TALDO1, PRPS1 | More | | Caffeine | hsa01230 | Biosynthesis of amino acids | 1.16E-03 | 4 | P51854, P60891, P15104, P37837 | TKTL1, PRPS1, GLUL, TALDO1 | More | | Caffeine | hsa01522 | Endocrine resistance | 5.79E-03 | 6 | P22694, Q02750, Q9UM47, P46527, P10415, Q13323 | PRKACB, MAP2K1, NOTCH3, CDKN1B, BCL2, BIK | More | | Caffeine | hsa02010 | ABC transporters | 4.93E-02 | 1 | Q8IZY2 | ABCA7 | More | | Caffeine | hsa03013 | RNA transport | 1.39E-04 | 12 | O14980, Q09161, O14893, Q7Z3B4, P35658, P47813, Q14152, O75822, Q14240, Q9BZI7, Q06787, P51114 | XPO1, NCBP1, GEMIN2, NUP54, NUP214, EIF1AX, EIF3A, EIF3J, EIF4A2, UPF3B, FMR1, FXR1 | More | | Caffeine | hsa03022 | Basal transcription factors | 3.50E-02 | 3 | P20226, O00268, Q15544 | TBP, TAF4, TAF11 | More | | Caffeine | hsa03040 | Spliceosome | 1.34E-04 | 14 | Q14562, O43143, O60508, P17844, P08579, O75940, P51991, P61978, O75494, Q07955, Q01130, Q13243, P11142, O43447 | DHX8, DHX15, CDC40, DDX5, SNRPB2, SMNDC1, HNRPA3, HNRPK, FUSIP1, SFRS1, SFRS2, SFRS5, HSPA8, PPIH | More | | Caffeine | hsa03050 | Proteasome | 4.83E-02 | 1 | P55036 | PSMD4 | More | | Caffeine | hsa03450 | Non-homologous end-joining | 4.48E-03 | 1 | P78527 | PRKDC | More | | Caffeine | hsa04014 | Ras signaling pathway | 2.21E-03 | 12 | Q02750, P20827, Q15389, Q9NRA1, P49767, P17252, P21359, P0DP23, P62873, P62879, P19174, P22694 | MAP2K1, EFNA1, ANGPT1, PDGFC, VEGFC, PRKCA, NF1, CALM1, GNB1, GNB2, PLCG1, PRKACB | More | | Caffeine | hsa04015 | Rap1 signaling pathway | 4.58E-02 | 6 | P20827, Q9NRA1, P49767, P0DP23, P17252, P19174 | EFNA1, PDGFC, VEGFC, CALM1, PRKCA, PLCG1 | More | | Caffeine | hsa04020 | Calcium signaling pathway | 2.01E-02 | 6 | P17252, P19174, P0DP23, P20020, Q9NRA1, P49767 | PRKCA, PLCG1, CALM1, ATP2B1, PDGFC, VEGFC | More | | Caffeine | hsa04061 | Viral protein interaction with cytokine and cytokine receptor | 1.84E-02 | 7 | P51684, P32248, P09341, P02775, P25025, P47992, Q9UBD3 | CCR6, CCR7, CXCL1, PPBP, CXCR2, XCL1, XCL2 | More | | Caffeine | hsa04064 | NF-kappa B signaling pathway | 2.78E-04 | 11 | P10415, Q13489, O00463, Q04759, Q9UDY8, Q13077, Q16548, Q8WV28, Q13315, P24522, P09341 | BCL2, BIRC3, TRAF5, PRKCQ, MALT1, TRAF1, BCL2A1, BLNK, ATM, GADD45A, CXCL1 | More | | Caffeine | hsa04066 | HIF-1 signaling pathway | 4.48E-02 | 4 | P17252, Q15389, Q02750, P46527 | PRKCA, ANGPT1, MAP2K1, CDKN1B | More | | Caffeine | hsa04070 | Phosphatidylinositol signaling system | 4.40E-02 | 4 | P19174, P0DP23, P23743, P17252 | PLCG1, CALM1, DGKA, PRKCA | More | | Caffeine | hsa04071 | Sphingolipid signaling pathway | 6.78E-05 | 8 | P17252, P21453, Q9H228, P01375, Q13362, Q9BX95, Q16539, P10415 | PRKCA, S1PR1, EDG8, TNF, PPP2R5C, SGPP1, MAPK14, BCL2 | More | | Caffeine | hsa04080 | Neuroactive ligand-receptor interaction | 4.68E-05 | 9 | P08311, P28472, Q15722, P21453, Q9H228, O00398, P21730, Q16581, P07550 | CTSG, GABRB3, LTB4R, S1PR1, EDG8, P2RY10, C5AR1, C3AR1, ADRB2 | More | | Caffeine | hsa04110 | Cell cycle | 1.35E-02 | 1 | P78527 | PRKDC | More | | Caffeine | hsa04115 | p53 signaling pathway | 3.98E-02 | 5 | P24522, Q13315, Q53FA7, O95067, P10415 | GADD45A, ATM, TP53I3, CCNB2, BCL2 | More | | Caffeine | hsa04140 | Autophagy - animal | 4.74E-02 | 3 | P22694, Q14643, P10415 | PRKACB, ITPR1, BCL2 | More | | Caffeine | hsa04141 | Protein processing in endoplasmic reticulum | 1.91E-03 | 6 | P18848, Q15437, Q99941, P11142, P07900, Q9NR31 | ATF4, SEC23B, CREBL1, HSPA8, HSP90AA1, SAR1A | More | | Caffeine | hsa04142 | Lysosome | 4.27E-03 | 9 | Q99437, P08311, P43234, P25774, Q9UBR2, P06280, P49279, Q9Y6Q5, Q9UPM8 | ATP6V0B, CTSG, CTSO, CTSS, CTSZ, GLA, SLC11A1, AP1M2, AP4E1 | More | | Caffeine | hsa04145 | Phagosome | 1.83E-02 | 7 | Q15080, P14598, Q13509, P68371, Q13488, Q99437, P25774 | NCF4, NCF1, TUBB3, TUBB2C, TCIRG1, ATP6V0B, CTSS | More | | Caffeine | hsa04146 | Peroxisome | 4.83E-02 | 4 | O96011, P56589, Q9UKG9, O75521 | PEX11B, PEX3, CROT, ECI2 | More | | Caffeine | hsa04151 | PI3K-Akt signaling pathway | 3.91E-03 | 7 | P62753, P27348, P07900, P22105, Q99941, P18848, O00141 | RPS6, YWHAQ, HSP90AA1, TNXB, CREBL1, ATF4, SGK | More | | Caffeine | hsa04210 | Apoptosis | 4.99E-03 | 11 | Q13315, P10415, Q13489, O76075, P24522, Q16548, Q13077, P43234, Q9UBR2, P18848, Q14643 | ATM, BCL2, BIRC3, DFFB, GADD45A, BCL2A1, TRAF1, CTSO, CTSZ, ATF4, ITPR1 | More | | Caffeine | hsa04211 | Longevity regulating pathway | 2.72E-02 | 3 | P51828, Q99941, P18848 | ADCY7, CREBL1, ATF4 | More | | Caffeine | hsa04217 | Necroptosis | 1.36E-02 | 7 | P01568, P42224, P08238, Q6FI13, Q93077, O43633, Q08752 | IFNA21, STAT1, HSP90AB1, H2AC18; H2AC19, HIST1H2AC, CHMP2A, PPID | More | | Caffeine | hsa04261 | Adrenergic signaling in cardiomyocytes | 1.33E-03 | 7 | P07550, P51828, P22694, Q99941, P18848, Q13362, Q13557 | ADRB2, ADCY7, PRKACB, CREBL1, ATF4, PPP2R5C, CAMK2D | More | | Caffeine | hsa04340 | Hedgehog signaling pathway | 9.74E-03 | 3 | P22694, Q13635, P10415 | PRKACB, PTCH1, BCL2 | More | | Caffeine | hsa04350 | TGF-beta signaling pathway | 4.88E-02 | 1 | P37173 | TGFBR2 | More | | Caffeine | hsa04360 | Axon guidance | 2.88E-03 | 7 | P20936, P16333, P20827, O95631, P17252, P34925, P19174 | RASA1, NCK1, EFNA1, NTN1, PRKCA, RYK, PLCG1 | More | | Caffeine | hsa04380 | Osteoclast differentiation | 1.02E-02 | 6 | Q9UQC2, Q16539, P14778, O75015, P01375, Q8N149 | GAB2, MAPK14, IL1R1, FCGR3B, TNF, LILRA2 | More | | Caffeine | hsa04540 | Gap junction | 8.54E-05 | 7 | P17252, P22694, Q13509, P68371, Q02750, Q9NRA1, Q14643 | PRKCA, PRKACB, TUBB3, TUBB2C, MAP2K1, PDGFC, ITPR1 | More | | Caffeine | hsa04610 | Complement and coagulation cascades | 2.33E-03 | 1 | P0C0L4 | C4A | More | | Caffeine | hsa04612 | Antigen processing and presentation | 4.24E-05 | 9 | P13765, P48382, Q14953, P26715, P26717, Q13241, O43908, P01732, P01375 | HLA-DOB, RFX5, KIR2DS5, KLRC1, KLRC2, KLRD1, KLRC4, CD8A, TNF | More | | Caffeine | hsa04613 | Neutrophil extracellular trap formation | 1.55E-03 | 13 | P17252, O60603, P05164, P08246, Q9UM07, Q6FI13, Q15080, P20160, P08311, P21730, P21462, O43315, Q16539 | PRKCA, TLR2, MPO, ELA2, PADI4, H2AC18; H2AC19, NCF4, AZU1, CTSG, C5AR1, FPR1, AQP9, MAPK14 | More | | Caffeine | hsa04614 | Renin-angiotensin system | 1.52E-02 | 1 | P50052 | AGTR2 | More | | Caffeine | hsa04621 | NOD-like receptor signaling pathway | 2.27E-02 | 9 | Q9H1Y0, P43490, O00463, Q05823, P01375, P49913, P59665, P59666, P12838 | ATG5, PBEF1, TRAF5, RNASEL, TNF, CAMP, DEFA1; DEFA1B, DEFA3, DEFA4 | More | | Caffeine | hsa04623 | Cytosolic DNA-sensing pathway | 3.29E-02 | 2 | P01568, P25963 | IFNA21, NFKBIA | More | | Caffeine | hsa04625 | C-type lectin receptor signaling pathway | 3.87E-02 | 4 | Q9ULY5, P20749, P01375, Q16539 | CLEC4E, BCL3, TNF, MAPK14 | More | | Caffeine | hsa04650 | Natural killer cell mediated cytotoxicity | 4.40E-05 | 9 | P01375, O60880, P20963, Q13241, P26718, O75015, P26717, Q14953, P26715 | TNF, SH2D1A, CD247, KLRD1, KLRK1, FCGR3B, KLRC2, KIR2DS5, KLRC1 | More | | Caffeine | hsa04657 | IL-17 signaling pathway | 8.78E-05 | 12 | P25963, P08238, O00463, Q07955, Q16539, P49841, P19875, P14780, P04141, P80188, P01375, P06702 | NFKBIA, HSP90AB1, TRAF5, SFRS1, MAPK14, GSK3B, CXCL2, MMP9, CSF2, LCN2, TNF, S100A9 | More | | Caffeine | hsa04658 | Th1 and Th2 cell differentiation | 1.30E-02 | 7 | Q04759, P09693, Q16539, Q14765, P23771, Q9UL17, P13765 | PRKCQ, CD3G, MAPK14, STAT4, GATA3, TBX21, HLA-DOB | More | | Caffeine | hsa04659 | Th17 cell differentiation | 8.77E-03 | 3 | Q04759, Q9HBE5, P84022 | PRKCQ, IL21R, SMAD3 | More | | Caffeine | hsa04660 | T cell receptor signaling pathway | 3.54E-03 | 13 | P04141, P25963, Q9UDY8, Q04759, P10747, O95267, Q08881, P19174, P16333, P09693, P01732, P29350, Q16539 | CSF2, NFKBIA, MALT1, PRKCQ, CD28, RASGRP1, ITK, PLCG1, NCK1, CD3G, CD8A, PTPN6, MAPK14 | More | | Caffeine | hsa04662 | B cell receptor signaling pathway | 1.49E-03 | 5 | P42338, P60033, P07948, P21854, Q8N149 | PIK3CB, CD81, LYN, CD72, LILRA2 | More | | Caffeine | hsa04664 | Fc epsilon RI signaling pathway | 2.20E-03 | 6 | P01375, Q16539, P42338, Q9UQC2, P07948, P09917 | TNF, MAPK14, PIK3CB, GAB2, LYN, ALOX5 | More | | Caffeine | hsa04668 | TNF signaling pathway | 2.12E-03 | 7 | P01375, O00463, Q16539, P18848, P19875, P20749, P14780 | TNF, TRAF5, MAPK14, ATF4, CXCL2, BCL3, MMP9 | More | | Caffeine | hsa04670 | Leukocyte transendothelial migration | 4.37E-02 | 7 | P14780, P13612, P17252, Q16539, Q15080, Q08881, P42681 | MMP9, ITGA4, PRKCA, MAPK14, NCF4, ITK, TXK | More | | Caffeine | hsa04672 | Intestinal immune network for IgA production | 1.55E-02 | 3 | P10747, P13765, P13612 | CD28, HLA-DOB, ITGA4 | More | | Caffeine | hsa04713 | Circadian entrainment | 3.32E-02 | 4 | P0DP23, P17252, P62873, O15055 | CALM1, PRKCA, GNB1, PER2 | More | | Caffeine | hsa04714 | Thermogenesis | 3.31E-02 | 4 | P51828, P62753, P12074, O15239 | ADCY7, RPS6, COX6A1, NDUFA1 | More | | Caffeine | hsa04720 | Long-term potentiation | 1.09E-02 | 4 | P17252, P51812, P22694, Q02750 | PRKCA, RPS6KA3, PRKACB, MAP2K1 | More | | Caffeine | hsa04723 | Retrograde endocannabinoid signaling | 2.28E-02 | 5 | Q14643, P17252, P22694, Q16539, Q16718 | ITPR1, PRKCA, PRKACB, MAPK14, NDUFA5 | More | | Caffeine | hsa04724 | Glutamatergic synapse | 5.94E-03 | 4 | O15399, P63218, P50151, P15104 | GRIN2D, GNG5, GNG10, GLUL | More | | Caffeine | hsa04725 | Cholinergic synapse | 4.09E-06 | 12 | P51828, P22694, Q14643, P17252, P62879, P63218, P50151, P18848, Q13557, P42338, P10415, Q02750 | ADCY7, PRKACB, ITPR1, PRKCA, GNB2, GNG5, GNG10, ATF4, CAMK2D, PIK3CB, BCL2, MAP2K1 | More | | Caffeine | hsa04726 | Serotonergic synapse | 2.43E-02 | 4 | P22694, P17252, P62879, Q02750 | PRKACB, PRKCA, GNB2, MAP2K1 | More | | Caffeine | hsa04727 | GABAergic synapse | 1.08E-03 | 7 | P62879, P63218, P50151, P15104, P22694, O60296, P17252 | GNB2, GNG5, GNG10, GLUL, PRKACB, TRAK2, PRKCA | More | | Caffeine | hsa04728 | Dopaminergic synapse | 4.78E-02 | 3 | Q99941, P18848, Q13557 | CREBL1, ATF4, CAMK2D | More | | Caffeine | hsa04744 | Phototransduction | 1.18E-02 | 2 | P62873, P0DP23 | GNB1, CALM1 | More | | Caffeine | hsa04750 | Inflammatory mediator regulation of TRP channels | 3.39E-02 | 5 | P22694, Q16539, Q14643, P17252, Q04759 | PRKACB, MAPK14, ITPR1, PRKCA, PRKCQ | More | | Caffeine | hsa04911 | Insulin secretion | 4.03E-04 | 4 | P51828, Q99941, P18848, Q13557 | ADCY7, CREBL1, ATF4, CAMK2D | More | | Caffeine | hsa04912 | GnRH signaling pathway | 4.73E-03 | 7 | P17252, P51828, P18848, Q13557, Q16539, Q14643, P22694 | PRKCA, ADCY7, ATF4, CAMK2D, MAPK14, ITPR1, PRKACB | More | | Caffeine | hsa04913 | Ovarian steroidogenesis | 1.27E-03 | 2 | P42330, P22694 | AKR1C3, PRKACB | More | | Caffeine | hsa04915 | Estrogen signaling pathway | 9.55E-04 | 9 | P14780, P22694, Q99941, P18848, P51828, P07900, P11142, Q14643, P10415 | MMP9, PRKACB, CREBL1, ATF4, ADCY7, HSP90AA1, HSPA8, ITPR1, BCL2 | More | | Caffeine | hsa04918 | Thyroid hormone synthesis | 6.10E-04 | 6 | P22694, P51828, Q99941, P18848, Q14643, P02768 | PRKACB, ADCY7, CREBL1, ATF4, ITPR1, ALB | More | | Caffeine | hsa04919 | Thyroid hormone signaling pathway | 2.22E-02 | 5 | P17252, Q02750, P22694, Q12778, Q9UM47 | PRKCA, MAP2K1, PRKACB, FOXO1, NOTCH3 | More | | Caffeine | hsa04922 | Glucagon signaling pathway | 4.80E-02 | 5 | P22694, P06737, Q12778, Q14643, P07195 | PRKACB, PYGL, FOXO1, ITPR1, LDHB | More | | Caffeine | hsa04924 | Renin secretion | 2.90E-04 | 3 | P22694, P07550, Q14643 | PRKACB, ADRB2, ITPR1 | More | | Caffeine | hsa04925 | Aldosterone synthesis and secretion | 1.69E-03 | 4 | Q99941, P18848, P51828, Q13557 | CREBL1, ATF4, ADCY7, CAMK2D | More | | Caffeine | hsa04926 | Relaxin signaling pathway | 3.75E-05 | 11 | P42338, P63218, P50151, Q99941, P18848, P22694, P49767, P14780, P51828, P30679, P49407 | PIK3CB, GNG5, GNG10, CREBL1, ATF4, PRKACB, VEGFC, MMP9, ADCY7, GNA15, ARRB1 | More | | Caffeine | hsa04927 | Cortisol synthesis and secretion | 6.24E-07 | 5 | Q14643, Q99941, P18848, P51828, P22694 | ITPR1, CREBL1, ATF4, ADCY7, PRKACB | More | | Caffeine | hsa04928 | Parathyroid hormone synthesis, secretion and action | 2.23E-06 | 10 | Q14643, P51828, P22694, P23771, Q02750, P17252, Q99941, P18848, P10415, Q9Y5Q3 | ITPR1, ADCY7, PRKACB, GATA3, MAP2K1, PRKCA, CREBL1, ATF4, BCL2, MAFB | More | | Caffeine | hsa04929 | GnRH secretion | 4.62E-02 | 2 | P42338, P49407 | PIK3CB, ARRB1 | More | | Caffeine | hsa04933 | AGE-RAGE signaling pathway in diabetic complications | 1.72E-02 | 5 | P42224, Q12778, P49767, P17252, P19174 | STAT1, FOXO1, VEGFC, PRKCA, PLCG1 | More | | Caffeine | hsa04934 | Cushing syndrome | 2.44E-04 | 7 | Q14643, Q99941, P18848, P51828, P22694, Q13557, P04628 | ITPR1, CREBL1, ATF4, ADCY7, PRKACB, CAMK2D, WNT1 | More | | Caffeine | hsa04935 | Growth hormone synthesis, secretion and action | 2.72E-02 | 3 | P51828, Q99941, P18848 | ADCY7, CREBL1, ATF4 | More | | Caffeine | hsa04964 | Proximal tubule bicarbonate reclamation | 4.93E-02 | 1 | P00918 | CA2 | More | | Caffeine | hsa04966 | Collecting duct acid secretion | 4.93E-02 | 1 | P00918 | CA2 | More | | Caffeine | hsa04970 | Salivary secretion | 1.18E-04 | 5 | P07550, P22694, Q14643, P17252, P49913 | ADRB2, PRKACB, ITPR1, PRKCA, CAMP | More | | Caffeine | hsa05012 | Parkinson disease | 3.12E-02 | 6 | Q16718, O14521, P19174, P0DP23, Q13509, P68371 | NDUFA5, SDHD, PLCG1, CALM1, TUBB3, TUBB2C | More | | Caffeine | hsa05014 | Amyotrophic lateral sclerosis | 2.72E-02 | 10 | P01375, Q16718, O14521, P36542, P09651, Q7Z3B4, P35658, P43243, Q09161, Q16629 | TNF, NDUFA5, SDHD, ATP5C1, HNRNPA1, NUP54, NUP214, MATR3, NCBP1, SFRS7 | More | | Caffeine | hsa05022 | Pathways of neurodegeneration - multiple diseases | 2.29E-02 | 9 | Q13509, P68371, Q16718, O14521, Q13561, P19174, P17252, Q08752, P0DP23 | TUBB3, TUBB2C, NDUFA5, SDHD, DCTN2, PLCG1, PRKCA, PPID, CALM1 | More | | Caffeine | hsa05030 | Cocaine addiction | 4.87E-02 | 2 | Q99941, P18848 | CREBL1, ATF4 | More | | Caffeine | hsa05031 | Amphetamine addiction | 8.84E-04 | 5 | Q13557, P22694, Q99941, P18848, Q13547 | CAMK2D, PRKACB, CREBL1, ATF4, HDAC1 | More | | Caffeine | hsa05110 | Vibrio cholerae infection | 2.60E-03 | 4 | Q13488, Q99437, P17252, P19174 | TCIRG1, ATP6V0B, PRKCA, PLCG1 | More | | Caffeine | hsa05132 | Salmonella infection | 1.70E-02 | 8 | P25963, P08238, P04406, O75369, Q13561, Q13509, P68371, P49754 | NFKBIA, HSP90AB1, GAPDH, FLNB, DCTN2, TUBB3, TUBB2C, VPS41 | More | | Caffeine | hsa05133 | Pertussis | 4.20E-02 | 1 | P0C0L4 | C4A | More | | Caffeine | hsa05140 | Leishmaniasis | 1.72E-02 | 5 | P14598, P42224, P25963, P29350, Q15080 | NCF1, STAT1, NFKBIA, PTPN6, NCF4 | More | | Caffeine | hsa05143 | African trypanosomiasis | 1.31E-02 | 2 | P69905, P68871 | HBA2, HBB | More | | Caffeine | hsa05144 | Malaria | 1.94E-04 | 6 | P60033, P69905, P68871, P01375, P35443, P26718 | CD81, HBA2, HBB, TNF, THBS4, KLRK1 | More | | Caffeine | hsa05146 | Amoebiasis | 2.41E-02 | 4 | P19875, P01375, P30679, P22694 | CXCL2, TNF, GNA15, PRKACB | More | | Caffeine | hsa05150 | Staphylococcus aureus infection | 1.19E-05 | 8 | P21730, P21462, O75015, Q14532, P59665, P59666, P12838, P49913 | C5AR1, FPR1, FCGR3B, KRT32, DEFA1; DEFA1B, DEFA3, DEFA4, CAMP | More | | Caffeine | hsa05152 | Tuberculosis | 4.16E-02 | 2 | Q99437, P25774 | ATP6V0B, CTSS | More | | Caffeine | hsa05161 | Hepatitis B | 3.34E-02 | 3 | Q99941, P18848, P27348 | CREBL1, ATF4, YWHAQ | More | | Caffeine | hsa05163 | Human cytomegalovirus infection | 2.80E-02 | 6 | P01375, P49841, P14778, P25025, Q16539, O00463 | TNF, GSK3B, IL1R1, CXCR2, MAPK14, TRAF5 | More | | Caffeine | hsa05165 | Human papillomavirus infection | 4.71E-03 | 10 | P46527, Q02750, P35443, Q92796, Q05086, Q9UM47, P22694, Q13362, Q12778, Q13315 | CDKN1B, MAP2K1, THBS4, DLG3, UBE3A, NOTCH3, PRKACB, PPP2R5C, FOXO1, ATM | More | | Caffeine | hsa05167 | Kaposi sarcoma-associated herpesvirus infection | 5.71E-03 | 8 | P01568, P42224, P25963, P40189, P62873, P19174, P04141, P0DP23 | IFNA21, STAT1, NFKBIA, IL6ST, GNB1, PLCG1, CSF2, CALM1 | More | | Caffeine | hsa05168 | Herpes simplex virus 1 infection | 4.15E-03 | 12 | P25963, P01568, Q9GZY0, P42224, Q07955, Q01130, Q13243, Q13398, Q03923, P52738, O75820, Q9UDV6 | NFKBIA, IFNA21, NXF2; NXF2B, STAT1, SFRS1, SFRS2, SFRS5, ZNF211, ZNF85, ZNF140, ZNF189, ZNF212 | More | | Caffeine | hsa05169 | Epstein-Barr virus infection | 3.72E-02 | 6 | Q13547, P42338, P07948, Q13761, O75293, P07766 | HDAC1, PIK3CB, LYN, RUNX3, GADD45B, CD3E | More | | Caffeine | hsa05171 | Coronavirus disease - COVID-19 | 1.36E-02 | 7 | P25963, P42224, P01568, P40189, P04141, P19174, P17252 | NFKBIA, STAT1, IFNA21, IL6ST, CSF2, PLCG1, PRKCA | More | | Caffeine | hsa05200 | Pathways in cancer | 1.75E-02 | 14 | P08238, P42224, P25963, P19174, P17252, P43246, P14923, P49767, Q12778, P62873, O75293, P0DP23, P01568, P40189 | HSP90AB1, STAT1, NFKBIA, PLCG1, PRKCA, MSH2, JUP, VEGFC, FOXO1, GNB1, GADD45B, CALM1, IFNA21, IL6ST | More | | Caffeine | hsa05202 | Transcriptional misregulation in cancer | 1.63E-05 | 17 | Q12778, Q15532, Q13315, P41732, P14780, Q15744, Q16548, Q13489, Q13077, O15550, P46527, P35226, P05164, P12838, P08246, Q9C0K0, P24522 | FOXO1, SS18, ATM, TSPAN7, MMP9, CEBPE, BCL2A1, BIRC3, TRAF1, UTX, CDKN1B, BMI1, MPO, DEFA4, ELA2, BCL11B, GADD45A | More | Genes in community(ComG) | Gene name of ComG | Protein name of ComG | Co-expressed genes in pathway (PathG) | Gene name of PathG | Protein name of PathG | Coexpression |
---|
Q14643 | ITPR1 | Inositol 1,4,5-trisphosphate receptor type 1 | Q12778 | FOXO1 | Forkhead box protein O1 | 0.729 | Q13315 | ATM | Serine-protein kinase ATM | Q12778 | FOXO1 | Forkhead box protein O1 | 0.821 | Q14643 | ITPR1 | Inositol 1,4,5-trisphosphate receptor type 1 | Q15532 | SS18 | Protein SSXT | 0.771 | P05164 | MPO | Myeloperoxidase | Q15532 | SS18 | Protein SSXT | -0.719 | Q13315 | ATM | Serine-protein kinase ATM | Q13315 | ATM | Serine-protein kinase ATM | 1 | P05164 | MPO | Myeloperoxidase | Q13315 | ATM | Serine-protein kinase ATM | -0.725 | Q14643 | ITPR1 | Inositol 1,4,5-trisphosphate receptor type 1 | P41732 | TSPAN7 | Tetraspanin-7 | -0.789 | Q14643 | ITPR1 | Inositol 1,4,5-trisphosphate receptor type 1 | P14780 | MMP9 | Matrix metalloproteinase-9 | -0.81 | P05164 | MPO | Myeloperoxidase | P14780 | MMP9 | Matrix metalloproteinase-9 | 0.812 | Q13315 | ATM | Serine-protein kinase ATM | Q15744 | CEBPE | CCAAT/enhancer-binding protein epsilon | -0.709 | P05164 | MPO | Myeloperoxidase | Q15744 | CEBPE | CCAAT/enhancer-binding protein epsilon | 0.799 | Q14643 | ITPR1 | Inositol 1,4,5-trisphosphate receptor type 1 | Q16548 | BCL2A1 | Bcl-2-related protein A1 | -0.822 | P05164 | MPO | Myeloperoxidase | Q16548 | BCL2A1 | Bcl-2-related protein A1 | 0.782 | Q14643 | ITPR1 | Inositol 1,4,5-trisphosphate receptor type 1 | Q13489 | BIRC3 | Baculoviral IAP repeat-containing protein 3 | 0.701 | Q14643 | ITPR1 | Inositol 1,4,5-trisphosphate receptor type 1 | Q13077 | TRAF1 | TNF receptor-associated factor 1 | 0.768 | Q14643 | ITPR1 | Inositol 1,4,5-trisphosphate receptor type 1 | O15550 | UTX | Lysine-specific demethylase 6A | -0.767 | P05164 | MPO | Myeloperoxidase | O15550 | UTX | Lysine-specific demethylase 6A | 0.763 | Q13315 | ATM | Serine-protein kinase ATM | P46527 | CDKN1B | Cyclin-dependent kinase inhibitor 1B | 0.708 | Q14643 | ITPR1 | Inositol 1,4,5-trisphosphate receptor type 1 | P35226 | BMI1 | Polycomb complex protein BMI-1 | 0.703 | Q14643 | ITPR1 | Inositol 1,4,5-trisphosphate receptor type 1 | P35226 | BMI1 | Polycomb complex protein BMI-1 | 0.703 | Q14643 | ITPR1 | Inositol 1,4,5-trisphosphate receptor type 1 | P05164 | MPO | Myeloperoxidase | -0.818 | Q13315 | ATM | Serine-protein kinase ATM | P05164 | MPO | Myeloperoxidase | -0.725 | P05164 | MPO | Myeloperoxidase | P05164 | MPO | Myeloperoxidase | 1 | P05164 | MPO | Myeloperoxidase | P12838 | DEFA4 | Neutrophil defensin 4 | 0.733 | Q14643 | ITPR1 | Inositol 1,4,5-trisphosphate receptor type 1 | P08246 | ELA2 | Neutrophil elastase | -0.816 | Q13315 | ATM | Serine-protein kinase ATM | P08246 | ELA2 | Neutrophil elastase | -0.742 | P05164 | MPO | Myeloperoxidase | P08246 | ELA2 | Neutrophil elastase | 0.903 | Q14643 | ITPR1 | Inositol 1,4,5-trisphosphate receptor type 1 | Q9C0K0 | BCL11B | B-cell lymphoma/leukemia 11B | 0.925 | Q13315 | ATM | Serine-protein kinase ATM | Q9C0K0 | BCL11B | B-cell lymphoma/leukemia 11B | 0.741 | P05164 | MPO | Myeloperoxidase | Q9C0K0 | BCL11B | B-cell lymphoma/leukemia 11B | -0.854 | Q14643 | ITPR1 | Inositol 1,4,5-trisphosphate receptor type 1 | P24522 | GADD45A | Growth arrest and DNA damage-inducible protein GADD45 alpha | -0.853 | P05164 | MPO | Myeloperoxidase | P24522 | GADD45A | Growth arrest and DNA damage-inducible protein GADD45 alpha | 0.812 |
| Caffeine | hsa05203 | Viral carcinogenesis | 1.46E-02 | 4 | Q99941, P18848, P27348, P61978 | CREBL1, ATF4, YWHAQ, HNRPK | More | | Caffeine | hsa05205 | Proteoglycans in cancer | 3.68E-02 | 5 | P14780, P01375, P23588, Q13635, P22694 | MMP9, TNF, EIF4B, PTCH1, PRKACB | More | | Caffeine | hsa05206 | MicroRNAs in cancer | 3.66E-02 | 6 | P46527, Q9UM47, P16070, Q13315, P17252, Q02750 | CDKN1B, NOTCH3, CD44, ATM, PRKCA, MAP2K1 | More | | Caffeine | hsa05212 | Pancreatic cancer | 3.40E-02 | 1 | P37173 | TGFBR2 | More | | Caffeine | hsa05214 | Glioma | 1.09E-02 | 4 | P0DP23, P17252, P19174, O75293 | CALM1, PRKCA, PLCG1, GADD45B | More | | Caffeine | hsa05231 | Choline metabolism in cancer | 2.25E-03 | 5 | Q9NRA1, Q9Y259, P19174, P23743, P17252 | PDGFC, CHKB, PLCG1, DGKA, PRKCA | More | | Caffeine | hsa05235 | PD-L1 expression and PD-1 checkpoint pathway in cancer | 3.98E-03 | 10 | P25963, O95267, P19174, P09693, P29350, P42224, O60603, P10747, Q04759, Q16539 | NFKBIA, RASGRP1, PLCG1, CD3G, PTPN6, STAT1, TLR2, CD28, PRKCQ, MAPK14 | More | | Caffeine | hsa05321 | Inflammatory bowel disease | 2.74E-06 | 8 | O60603, P01375, P13765, Q14765, Q9UL17, P23771, P84022, Q9HBE5 | TLR2, TNF, HLA-DOB, STAT4, TBX21, GATA3, SMAD3, IL21R | More | | Caffeine | hsa05332 | Graft-versus-host disease | 9.06E-06 | 5 | P13765, P10747, P01375, P26715, Q13241 | HLA-DOB, CD28, TNF, KLRC1, KLRD1 | More | | Caffeine | hsa05340 | Primary immunodeficiency | 3.73E-02 | 2 | P11912, P16871 | CD79A, IL7R | More | | Caffeine | hsa05412 | Arrhythmogenic right ventricular cardiomyopathy | 4.93E-02 | 1 | P54284 | CACNB3 | More | | Caffeine | hsa05415 | Diabetic cardiomyopathy | 1.20E-02 | 6 | P17252, P14598, Q15080, Q16718, O14521, P04406 | PRKCA, NCF1, NCF4, NDUFA5, SDHD, GAPDH | More | | Caffeine | hsa05418 | Fluid shear stress and atherosclerosis | 1.08E-03 | 7 | Q16539, Q14145, P10599, P14780, P01375, P14778, P27930 | MAPK14, KEAP1, TXN, MMP9, TNF, IL1R1, IL1R2 | More | | |